PRAN makes hay, SIRI sells, KNDI hobbled

Prana Biotechnology (NASDAQ : PRAN) vaulted 7.6% to $2.83, on volume of 2.5 million or 2 ½ times its daily average. This, after announcing that the Alzheimer’s Drug Discovery Foundation will provide Prana with a mission-related investment of $700,000 over two years to conduct a clinical trial investigating the potential of PBT2 to reduce the accumulation of beta-amyloid in the brain of people with Alzheimer’s Disease.

Sirius XM Radio Inc. (Nasdaq: SIRI) beamed out 43.6 million shares Thursday, catching up on its daily average of 52.6 million. Prices subsided, though, 4.1%, to $1.64, amid word that its antitrust lawsuit has been approved for class-action status.

Kandi Technologies, Corp. (NASDAQ: KNDI) shares dipped 12.5% to $2.95. Volume for KNDI was 367,558, closing the gap with its daily average of around 380,000, after it reported 2010 revenues increased 26.8% to $42.9 million. On a non-GAAP basis, which excludes certain warrants, options and convertible notes related charges, the Company reported 2010 adjusted net income of $5.0 million, up 76% from the prior year.

Tags: buzz stocks, consumer discretionary, healthcare, KNDI, nasdaq, PRAN, siri, Technology Stocks

This entry was posted on Thursday, March 31st, 2011 at 11:21 am by Glenn and is filed under Consumer Discretionary Stocks, Health Care Stocks, Technology Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.